Psychometric evaluation of ADAS-Cog and NTB for measuring drug response.

Abstract

AIMS To conduct a psychometric analysis to determine the adequacy of instruments that measure cognition in Alzheimer's disease trials. BACKGROUND Both the Alzheimer's Disease Assessment Scale - Cognition (ADAS-Cog) and the Neuropsychological Test Battery (NTB) are validated outcome measures for clinical trials in Alzheimer's disease and are approved also… (More)
DOI: 10.1111/ane.12153

Topics

Cite this paper

@article{Karin2014PsychometricEO, title={Psychometric evaluation of ADAS-Cog and NTB for measuring drug response.}, author={Aleksandra Karin and Kristin Hannesdottir and J Jaeger and Peter Annas and M{\"a}rta Segerdahl and Per Karlsson and Niclas Sj{\"{o}gren and Thomas von Rosen and Francine Miller}, journal={Acta neurologica Scandinavica}, year={2014}, volume={129 2}, pages={114-22} }